TCG Labs-Soleil
- Biotech or pharma, therapeutic R&D
- Investor (buy-side or sell-side research)
TCG Labs Soleil is a pioneering venture-biotech model, established in collaboration with The Column Group. Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset biologic programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.
Address
South San FranciscoCalifornia
United States